Board denies recall of anti-malaria drug from Kenyan market


Board denies recall of anti-malaria drug from Kenyan market

In Summary

  • The Board said Duo-Cotexcin is only under quarantine pending investigations after failing a quality test.
  • On Thursday, an official had indicated that Duo-Cotexcin would no longer be imported or sold in the market.
  • Ms. Jacinter Wasike, Director of Inspection, Surveillance and Enforcement told reporters in Kisumu that the move was due to safety concerns.

The Pharmacy and Poisons Board has denied reports that an anti-malaria drug has been recalled from the Kenyan market.

The Board said Duo-Cotexcin is only under quarantine pending investigations after failing a quality test.

“No recall or withdrawal is being conducted for the above product. The Pharmacy and Poisons Board is undertaking investigations to ascertain the suspected quality defect on that specific batch No 160621,” a statement sent to newsrooms said.

On Thursday, an official from the Board had indicated that Duo-Cotexcin would no longer be imported or sold in the Kenyan market.

Ms. Jacinter Wasike, Director of Inspection, Surveillance and Enforcement told reporters in Kisumu that the move was due to safety concerns.

For Citizen TV updates
Join @citizentvke Telegram channel



Video Of The Day: Nairobi County proposes higher taxes for city residents

Avatar
Story By Rachel Ombaka
More by this author